Elevating Expectations: Vericiguat in Heart Failure with Reduced Ejection Fraction
Introduction: Heart failure (HF) with reduced ejection fraction (EF) poses high morbidity and mortality. Guidelines Directed Medical Therapy (GDMT) is essential, yet many patients experience significant symptoms. Vericiguat, a soluble guanylate cyclase stimulator, may serve as an adjunctive therapy...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wolters Kluwer Medknow Publications
2024-12-01
|
| Серія: | Journal of Pharmacy and Bioallied Sciences |
| Предмети: | |
| Онлайн доступ: | https://journals.lww.com/10.4103/jpbs.jpbs_1392_24 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|